Yellow Corporation Bringing New Jobs to Maybrook, New York & America

OVERLAND PARK, Kan., May 03, 2021 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) is recruiting employees for new positions in Maybrook, New York. On Wednesday, May 5, Yellow will host a hiring event as the trucking company looks to fill jobs including dock workers, local drivers (full-time position includes a $7,500 hiring bonus), and linehaul drivers (includes a $7,500 hiring bonus). Yellow intends to hire qualified individuals immediately for 53 jobs in Maybrook with more positions open nationwide.

Yellow is the second largest less-than-truckload carrier and the fifth largest transportation company in North America. Yellow’s 30,000 employees are based in all 50 states as well as Puerto Rico, Canada and Mexico.

Yellow’s Maybrook hiring event is among more than two dozen similar recruiting events taking place across America between now and July. By the end of 2021, Yellow aims to hire thousands of new employees nationwide with at least 1,500 of those positions earmarked for commercial drivers.

“Seventy percent of America’s freight moves on our nation’s highways, so it’s essential that the industry continue to ramp up hiring to keep the U.S. supply chain humming along,” said Darren Hawkins, Chief Executive Officer of Yellow.

“Yellow pays very competitive wages and offers outstanding healthcare benefits for employees,” said Mr. Hawkins. “For those with trucking experience or not, or folks looking for a new opportunity or needing to make a job change due to pandemic fallout, it’s an exciting time to build a career and a future at Yellow.”

In addition to the May 5 recruiting day, Yellow continues to regularly sponsor its Maybrook Driver Academy, which provides classroom and road training for those interested in careers as commercial drivers.

“Hiring is our number one priority,” said Hawkins. “Our freight professionals serve as the economic lifeline to nearly every community in America. Transportation and trucking people are patriots.”

On Wednesday, May 5, Yellow’s recruiting event will take place at its YRC Freight Maybrook terminal, 1000 Homestead Avenue, Maybrook, New York, from 9:00 AM – 4:00 PM. Candidates will have the opportunity to interview with hiring managers and receive assistance with applications and paperwork. No reservation is necessary.

Yellow regularly sponsors its Maybrook Driving Academy for qualified candidates who are interested in obtaining a Commercial Driver’s License (CDL) tuition-free. For information on dates, please contact Yellow at (833) 475-8201.

For more information or to apply, please visit www.MyYellow.com, and click “Careers” in the top right.

About Yellow Corporation

Yellow Corporation has one of the largest, most comprehensive logistics and less-than-truckload (LTL) networks in North America with local, regional, national, and international capabilities. Through its teams of experienced service professionals, Yellow Corporation offers industry-leading expertise in flexible supply chain solutions, ensuring customers can ship industrial, commercial, and retail goods with confidence. Yellow Corporation, headquartered in Overland Park, Kan., is the holding company for a portfolio of LTL brands including Holland, New Penn, Reddaway, and YRC Freight, as well as the logistics company HNRY Logistics.

Please visit our website at www.myyellow.com for more information.

Media Contacts: Mike Kelley
  913-696-6121 Heather Nauert
  [email protected] [email protected]
     
Investor Contact: Tony Carreño  
  913-696-6108  
  [email protected]  



BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the Company will ring the NASDAQ closing bell on Wednesday, May 5, 2021, to highlight May as Mental Health Awareness Month.

“We are thrilled to have the opportunity to raise awareness of May as Mental Health Awareness Month by ringing the NASDAQ closing bell,” stated Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay. “The ongoing global COVID-19 pandemic has led to a significant rise in a multitude of mental health conditions, and it is critical that we highlight the various resources available to those in need. BrainsWay is dedicated to developing and providing advanced solutions for brain disorders using our revolutionary technology, Deep Transcranial Magnetic Stimulation, or Deep TMS, which has been utilized to treat over 100,000 patients for depression and obsessive-compulsive disorder. I would like to thank NASDAQ for their support in helping us drive recognition of the mental health crisis and the commitment of healthcare providers by allowing us to ring the closing bell on behalf of our dedicated team who strive each day to boldly advance neuroscience to improve health and transform lives.”

The ceremony will begin at approximately 3:45 p.m. ET on Wednesday, May 5, 2021, and can be viewed live at https://www.nasdaq.com/marketsite/bell-ringing-ceremony.

About BrainsWay

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies demonstrating clinically proven efficacy. Current indications include major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Cresskill, NJ and Jerusalem, Israel, BrainsWay is committed to increasing global awareness and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Company’s anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Company’s intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, and the effect of the global COVID-19 health pandemic on our business and continued uncertainty and market impact relating thereto.

Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward- looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s filings with the U.S. Securities and Exchange Commission, including the Company’s Annual Report on Form 20-F. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov.

Contacts:

BrainsWay:
Hadar Levy
SVP and General Manager
[email protected]

Investors:
Bob Yedid
LifeSci Advisors
646-597-6989
[email protected]



Beyond Air® Appoints Peter Senior as Director of Business Development

Former Director of Healthcare Partnerships and External Relations at Linde plc brings 26 years of experience to Beyond Air

GARDEN CITY, N.Y., May 03, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced the appointment of Peter Senior to Director of Business Development.

“I am thrilled to welcome Peter to Beyond Air at such a pivotal moment for the company,” said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. “Peter provides us with essential nitric oxide experience, bringing with him a wealth of knowledge of the global gas business. His skills will be instrumental to further the development of the LungFit® franchise, especially as we look to secure an ex-US partner for our leading candidate LungFit® PH.”

“Beyond Air’s commitment to expanding and simplifying therapeutic access to nitric oxide made my decision to join the team an easy one. I am excited to provide my expertise during this key phase of the development of Beyond Air,” said Peter Senior.

Peter Senior joins Beyond Air after spending 26 years at Linde plc where he most recently served as the Director of Healthcare Partnerships and External Relations. In this role, Peter was responsible for expanding Linde’s healthcare portfolio after the merger with Praxair, which made Linde the largest gas company in the world. Linde has sold INOmax® in over 20 countries outside the US over the past 15 years and recently entered the US nitric oxide market with the NOxBOXi® delivery system via the Praxair merger. Prior to the merger, Peter was Global Head of Marketing and Business Development for the hospital sector where he coordinated the marketing and business development activities of Linde’s global hospital business.

As Director of Business Development at Beyond Air, Peter will lead the global business development strategy and efforts for the LungFit® family.

About Beyond Air, Inc.

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit®, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. LungFit® can generate up to 400 ppm of NO, for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary LungFit® for clinical trials for the treatment of severe lung infections such as SARS-CoV-2 and nontuberculous mycobacteria (NTM). Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net.

About Nitric Oxide (NO)

Nitric Oxide (NO) is a powerful molecule, naturally synthesized in the human body, proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs. Currently, exogenous inhaled NO is used in adult respiratory distress syndrome, post certain cardiac surgeries and persistent pulmonary hypertension of the newborn to treat hypoxemia. Additionally, NO is believed to play a key role in the innate immune system and in vitro studies suggest that NO possesses anti-microbial activity not only against common bacteria, including both gram-positive and gram-negative, but also against other diverse pathogens, including mycobacteria, viruses, fungi, yeast and parasites, and has the potential to eliminate multi-drug resistant strains.

About LungFit®*

Beyond Air’s LungFit® is a cylinder-free, phasic flow nitric oxide generator and delivery system and has been designated as a medical device by the US Food and Drug Administration (FDA). The ventilator compatible version of the device can generate NO from ambient air on demand for delivery to the lungs at concentrations ranging from 1 part per million (ppm) to 80 ppm. LungFit® system could potentially replace large, high-pressure NO cylinders providing significant advantages in the hospital setting, including greatly reducing inventory and storage requirements, improving overall safety with the elimination of NO2 purging steps, and other benefits. LungFit® can also deliver NO at concentrations at or above 80 ppm for potentially treating severe acute lung infections in the hospital setting (e.g. COVID-19, bronchiolitis) and chronic, refractory lung infections in the home setting (e.g. NTM). With the elimination of cylinders, Beyond Air intends to offer NO treatment in the home setting.

* Beyond Air’s LungFit® is not approved for commercial use. Beyond Air’s LungFit® is for investigational use only. Beyond Air is not suggesting NO use over 80 ppm or use at home.

Forward Looking Statements

This press release contains “forward-looking statements” concerning inhaled nitric-oxide and the Company’s LungFit® product, including statements with regard to potential regulatory developments, the potential impact on patients and anticipated benefits associated with its use. Forward-looking statements include statements about our expectations, beliefs, or intentions regarding our product offerings, business, financial condition, results of operations, strategies or prospects. You can identify such forward-looking statements by the words “anticipates,” “expects,” “intends,” “impacts,” “plans,” “projects,” “believes,” “estimates,” “likely,” “goal,” “assumes,” “targets” and similar expressions and/or the use of future tense or conditional constructions (such as “will,” “may,” “could,” “should” and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause our actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking statements are only predictions and reflect our views as of the date they are made with respect to future events and financial performance. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including risks related to: our approach to discover and develop novel drugs, which is unproven and may never lead to efficacious or marketable products; our ability to fund and the results of further pre-clinical and clinical trials; obtaining, maintaining and protecting intellectual property utilized by our products; our ability to enforce our patents against infringers and to defend our patent portfolio against challenges from third parties; our ability to obtain additional funding to support our business activities; our dependence on third parties for development, manufacture, marketing, sales, and distribution of products; the successful development of our product candidates, all of which are in early stages of development; obtaining regulatory approval for products; competition from others using technology similar to ours and others developing products for similar uses; our dependence on collaborators; our short operating history and other risks identified and described in more detail in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and other filings with the SEC, all of which are available on our website. We undertake no obligation to update, and we do not have a policy of updating or revising, these forward-looking statements, except as required by applicable law.

CONTACTS:

Steven Lisi, Chief Executive Officer
Beyond Air, Inc.
[email protected]

Maria Yonkoski, Head of Investor Relations
Beyond Air, Inc.
[email protected]

Corey Davis, Ph.D.
LifeSci Advisors, LLC
[email protected]
(212) 915-2577



Accenture Named a Leader in Everest Group’s Veeva PEAK Services Matrix Assessment 2021

Accenture Named a Leader in Everest Group’s Veeva PEAK Services Matrix Assessment 2021

NEW YORK–(BUSINESS WIRE)–
Accenture (NYSE: ACN) has been named a leader in Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210503005172/en/

Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

Veeva helps life sciences enterprises manage customer databases, track drug development, and organize clinical trials. Everest Group assessed how 15 life sciences information technology (IT) providers’ use Veeva and named Accenture a leader for its market impact, vision, and capabilities.

“During the pandemic, the cloud has been invaluable to unlock data and improve collaboration across the ecosystem in the race to develop and get a vaccine to the world,” said Rob Saiter, managing director, Accenture Life Sciences. “The cloud is foundational to the digital transformation that will help speed treatment development and create more meaningful engagement with sites and patients to improve patient outcomes. Earning a leadership position in the Veeva PEAK Services Matrix Assessment is a testament to our teams’ expertise and successful partnering with our clients.”

The Everest Group Veeva PEAK Services Matrix® Assessment analyzed IT service providers’ Veeva services capabilities, including market trends for Veeva service and enterprise sourcing considerations highlighting the strengths and limitations of each service provider. Everest noted that Accenture has a strong focus on talent and has also invested in building accelerators, solutions, and frameworks to expedite time-to-market for their clients.

“Accenture’s expertise in guiding strategy for cloud capabilities and demonstrated ability to carry out large-scale transformational engagement covering Veeva’s large portfolio of offerings have earned Accenture its leadership position,” said Chunky Satija, practice director at Everest Group. “This is essential given an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, and it’s quite clear the industry is increasingly switching to cloud-based technologies.”

About Accenture

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 537,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Visit us at www.accenture.com.

Marchell Gillis

Accenture

+1.678.657.7515

+1.404.409.9430 (mobile)

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Data Management Security Technology Other Science Software Networks Science

MEDIA:

Photo
Photo
Everest Group’s Veeva Services PEAK Matrix Assessment 2021 (Graphic: Business Wire)

IIROC Trading Halt – VALU

Canada NewsWire

VANCOUVER, BC, May 3, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: Valorem Resources Inc.

CSE Symbol: VALU

All Issues: Yes

Reason: Halt Trade Order

Halt Time (ET): 7:45 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

Unisys Joins Panel to Provide Hyperscale Cloud Management Services to South Australian Government Agencies

The HCM panel provides State Agencies with a centralized approach to purchase hyperscale cloud services or third-party management of such services, to simplify cloud adoption and accelerate digital transformation

PR Newswire

ADELAIDE, Australia and BLUE BELL, Pa., May 3, 2021 /PRNewswire/ — Unisys Corporation (NYSE: UIS) today announced that it has been accepted to provide Hyperscale Cloud Management Services to South Australian government agencies via the government’s Managed Platform Services Panel. The HCM panel makes it easier for agencies to access cloud services from trusted suppliers.

This new panel is part of the South Australian government’s strategy to harness opportunities created by new technologies and new ways of working to develop and deliver better services for the people and businesses of South Australia.

Under the panel, Unisys is available to provide and manage cloud services on hyperscale cloud platforms such as Microsoft® Azure, Amazon Web Services (AWS) and Google Cloud Platform. These include Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Application Support. Unisys joined the panel in in the first quarter of 2021.

The Unisys Cloud Management Platform (CMP), which is a part of the CloudForte® suite of services and technologies, includes cloud management and operations services with tools and artificial intelligence for improving operations and providing rapid delivery of hybrid and multi-cloud solutions, while managing costs and performance. Unisys CloudForte services are designed to help organizations accelerate their cloud adoption, no matter where they are in the cloud journey – from legacy migration to new cloud design and deployment for hybrid and multi-cloud environments.

“The South Australian Government’s digital transformation strategy highlights the critical role of digital technologies in modernizing and transforming public services by not simply putting current processes online, but rather rethinking services for the digital age, to deliver better services to citizens,” said Andrew Whelan, vice president client management, Unisys Asia Pacific. “Unisys brings strong expertise in hybrid- and multi-cloud environments, with global cloud experience that spans 110 countries and more than 250 customers including highly-regulated industries. We understand how government policies need to be implemented as well as the regulatory and privacy requirements to protect data and information. As part of this panel, we look forward to helping South Australian government agencies streamline their transformation.”

Research indicates that a holistic approach to cloud transformation is fundamental for helping organizations achieve the business benefits and outcomes they expect. According to the Unisys Cloud Success Barometer™, the top reason Australian organizations reported they had not realized notable benefits from cloud computing was because they had not integrated their migration plan into their broader business transformation strategy. Unisys CloudForte services enable and support the holistic IT and organizational change required to integrate cloud adoption into the overall business strategy.

Unisys has a strong track record working with state and federal government agencies in Australia. More than 215 government agencies worldwide, and 20 in Asia Pacific, use Unisys solutions. For more information on Unisys’ public sector capabilities, click here.

About Unisys

Unisys is a global IT services company that delivers successful outcomes for the most demanding businesses and governments. Unisys offerings include digital workplace services, cloud and infrastructure services and software operating environments for high-intensity enterprise computing. Unisys integrates security into all of its solutions. For more information on how Unisys delivers for its clients across the government, financial services and commercial markets, visit www.unisys.com.

Follow Unisys on Twitter and LinkedIn.

RELEASE NO.: 0503/9829

Unisys and other Unisys products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of Unisys Corporation. Any other brand or product referenced herein is acknowledged to be a trademark or registered trademark of its respective holder.

UIS-C

Cision View original content:http://www.prnewswire.com/news-releases/unisys-joins-panel-to-provide-hyperscale-cloud-management-services-to-south-australian-government-agencies-301281759.html

SOURCE Unisys Corporation

Fairfax India Announces Filing of Prospectus by Chemplast Sanmar Limited

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES


(



Note



: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted.)

TORONTO, May 03, 2021 (GLOBE NEWSWIRE) — Fairfax India Holdings Corporation (“Fairfax India”) (TSX: FIH.U) announces that Chemplast Sanmar Limited (“CSL”), a subsidiary of Sanmar Chemicals Group (“Sanmar”), has filed a draft red herring prospectus with the Securities and Exchange Board of India (“SEBI”) in connection with its proposed initial public offering (the “IPO”).

Pursuant to the IPO, CSL may raise up to INR 35 billion (approximately $472 million at current exchange rates), comprised of a primary issuance of fresh equity shares of up to INR 15 billion ($202 million) and a secondary sale of CSL equity shares by the Sanmar group aggregating up to INR 20 billion ($270 million). Details regarding the price at which the equity shares will be sold and issued will be contained in the final prospectus to be filed with SEBI.

CSL is a leading specialty chemicals manufacturer in India with a focus on specialty paste PVC resin and custom manufacturing of starting materials and intermediates for the pharmaceutical, agro-chemical and fine chemical sectors. CSL also wholly-owns Chemplast Cuddalore Vinyls Limited, the second largest manufacturer of suspension PVC resin in India. Sanmar is the ultimate holding company of CSL.

Fairfax India currently owns 398,853 equity shares of Sanmar, representing a 42.9% equity interest in Sanmar (on a fully-diluted basis).

Fairfax India is an investment holding company whose objective is to achieve long term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in India and Indian businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, India.

For further information, contact: John Varnell, Vice President, Corporate Affairs
  (416) 367-4755



IIROC Trading Halt – RVV

Canada NewsWire

VANCOUVER, BC, May 3, 2021 /CNW/ – The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

CSE Symbol: RVV

All Issues: Yes

Reason: At the request of the Company Pending News

Halt Time (ET): 7:40 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) – Halts/Resumptions

CORRECTION: Caduceus Corp: McLovin’s Pet Food Receives Promotional Purchase Order from Kehe Distributors

This press release replaces the press release disseminated April 21st, 2021. The press release had out-of-date information about KeHE (second paragraph). The corrected press release is below:

PR Newswire

CHEYENNE, Wyo., May 3, 2021 /PRNewswire/ — CADUCEUS CORP, INC. (USOTC: CSOC) (“Caduceus” or the “Company”), a publicly traded holding company focused on strategic consumer goods acquisitions is pleased to announce that the Company’s acquisition target McLovin’s has received the 1st purchase order from Kehe Distributors LLC.

Kehe Food Distributors is a leading U.S. distributor of natural and specialty food products that fit the lifestyle of today’s consumer. The company was founded in 1952 and distributes more than 40,000 better-for-you products to more than 30,000 retail and online stores within the United States, as well as Mexico and the Caribbean. The company operates nearly 500 delivery trucks and 16 distribution centers are strategically located across the United States and Canada.

KeHE has agreed to promote McLovin’s to their customers. As first step, they will launch a campaign to reach up stores on the west coast. If the result is positive, they will expand the reach to include mid-west which they have even a stronger presence and bigger coverage.

“This is a big first step to having access to a distribution network of this size. We expect to receive positive feedback and a large order in the coming weeks from this promotional campaign. The Promotional model is designed to help showcase the latest and most innovative products to retailers and stores. Kehe customers’ count on the sampling to stock their shelves with the hottest deals from new and established brands and to learn the compelling stories behind the brand. Kehe’s distribution network will allow us to grow our business to the next level and develop meaningful connections with new retail partners from around the country,” said Alex Chen, Chief Executive Officer and Director of Caduceus.

About CADUCEUS CORP, Inc.

CADUCEUS CORP, Inc. is a Wyoming-based holding company focusing on the acquisition & merger of commercialized businesses. We are dedicated to supplying quality, healthy and innovative products and solutions. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “CSOC.”

About McLovin’s Pet Food, Inc

McLovin’s, Inc. is a California registered company focusing on the manufacturing and distribution of quality pet foods. We believe in real food. What you’ll find in McLovin’s is similar to what you’ll find in your own grocery cart. In the case of our premium treats, it starts (and ends) with real beef, chicken and salmon. Our products are developed using responsible sourcing and quality is a key part of every single part of our manufacturing process.

Corporate Website: https://mclovinspetfood.com

Forward-Looking Statements:

Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

For more information:
OTC Markets: (OTC Pink: CSOC)
Corporate Website: https://caduceuscorp.co
Email: [email protected]
Twitter: https://twitter.com/caduceuscorp 
+1-212-470-6997

Cision View original content:http://www.prnewswire.com/news-releases/correction-caduceus-corp-mclovins-pet-food-receives-promotional-purchase-order-from-kehe-distributors-301282060.html

SOURCE Caduceus Corp, Inc.

Power Corporation’s FinTech Strategy Creating Shareholder Value – Wealthsimple announces $750 million equity offering

Canada NewsWire

Readers are referred to the section “Forward-Looking Statements” at the end of this release. All figures are expressed in Canadian dollars.

MONTRÉAL, May 3, 2021 /CNW/ – Wealthsimple Financial Corp. (“Wealthsimple”), a member of the Power Corporation group of companies and one of Canada’s leading financial technology companies, issued a press release today announcing it has signed a $750 million financing round. The fundraising consists of a $250 million primary offering by Wealthsimple, as well as a $500 million secondary offering by Power Corporation of Canada (TSX: POW) (“Power Corporation” or “PCC”), IGM Financial Inc. (“IGM Financial”) and Great-West Lifeco Inc. (“Great-West Lifeco”) (collectively the “PCC Group”) pro-rata to their respective ownership interests. The transaction is subject to customary closing conditions and is expected to close by mid-May 2021. Additional details of the primary offering are disclosed in Wealthsimple’s press release issued earlier today.

The PCC Group is the largest shareholder of Wealthsimple holding a 62% equity interest, on a fully diluted basis with PCC, IGM Financial and Great-West Lifeco owning 23.1%, 36.3% and 2.3%, respectively. The PCC Group’s interest represents 76% of the voting rights. Following completion of the primary and secondary offerings, the PCC Group will continue to be the largest shareholder in Wealthsimple with a combined 43% equity interest, on a fully diluted basis, and 60% of the voting rights [1]. As a result of the secondary offering, the PCC Group will receive proceeds of $500 million and will retain an interest valued at $2.1 billion, a total increase in value of $1.7 billion from December 31, 2020 and $2.3 billion over the PCC Group’s invested capital of $315 million in Wealthsimple. This represents a multiple on invested capital of 8.3x and a compound annual return on investment of 79% (before expenses and taxes).

PCC currently holds a 23% equity interest in Wealthsimple, on a fully diluted basis. PCC will receive proceeds of $187 million ($164 million after-tax) from the secondary offering and will retain a 16% equity interest in Wealthsimple, on a fully diluted basis, valued at $796 million. PCC’s retained interest represents, along with proceeds from the secondary offering, an increase in value of approximately $633 million, or $0.94 per participating share, from December 31, 2020. 

Today, IGM Financial also announced the change in its ownership interest in Wealthsimple. IGM Financial will receive proceeds of $295 million ($260 million after-tax) from its pro-rata share of the secondary offering and will retain an interest valued at $1.15 billion. Additional details are disclosed in IGM Financial’s press release issued earlier today.

Wealthsimple is a key part of a portfolio of fintech investments that the PCC Group has cultivated through Portag3 Ventures (“Portag3”), the venture-capital arm of multi-asset class alternative investment platform Sagard Holdings. Investments in organizations such as Wealthsimple enhance the capabilities of PCC’s publicly traded operating companies while giving them exposure to new markets with favorable secular trends. Through Portag3, the PCC Group will continue to play an active role in Wealthsimple’s growth through Board membership and support from Portag3’s value creation team.

[1] Including a 3.8% interest held through a co-investment vehicle managed by Sagard Holdings.

Expected Impact of Wealthsimple’s Equity Offerings on PCC’s Consolidated Financial Statements [2]

In the first quarter ended March 31, 2021, the revised Wealthsimple valuation will result in a net increase in the liability related to put rights held by non-controlling interests and option holders of Wealthsimple of approximately $200 million recorded through the statement of earnings and a net carried interest expense of approximately $41 million.

In the second quarter ended June 30, 2021, pending a successful close of the transaction, the put rights will be extinguished. Following the close, the primary and secondary offerings and the extinguishment of the put rights will result in an increase in participating shareholders’ equity of approximately $0.7 billion recorded through the statement of changes in equity.

[2] All amounts disclosed are attributable to PCC participating shareholders.

About Wealthsimple

Wealthsimple is a financial company on a mission to help everyone achieve financial freedom, no matter who they are or how much they have. Using smart technology, Wealthsimple takes financial services that are often confusing, opaque and expensive and makes them simple, transparent, and low-cost. The company was founded by a team of financial experts and technology entrepreneurs, and is headquartered in Toronto, Canada. To learn more, visit www.wealthsimple.com.

About Power Corporation

Power Corporation is an international management and holding company that focuses on financial services in North America, Europe and Asia. Its core holdings are leading insurance, retirement, wealth management and investment businesses, including a portfolio of alternative asset investment platforms. To learn more, visit www.PowerCorporation.com.

Forward-Looking Statements

Certain statements in this news release, other than statements of historical fact, are forward-looking statements based on certain assumptions and reflect the Corporation’s current expectations. Forward-looking statements are provided to present information about management’s current expectations and plans relating to the future and the reader is cautioned that such statements may not be appropriate for other purposes. These statements may include, without limitation, statements regarding the operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, strategies and outlook of the Corporation, including the Corporation’s fintech strategy, the expected proceeds from the primary and secondary offerings and the resulting size and value of the ownership interests of members of the PCC Group, the extinguishing of the put rights, and the expected impact of matters on the Corporation’s financial statements. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as “expects”, “anticipates”, “plans”, “believes”, “estimates”, “seeks”, “intends”, “targets”, “projects”, “forecasts” or negative versions thereof and other similar expressions, or future or conditional verbs such as “may”, “will”, “should”, “would” and “could”.

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, many of which are beyond the Corporation’s and its subsidiaries’ control, affect the operations, performance and results of the Corporation and its subsidiaries and their businesses, and could cause actual results to differ materially from current expectations of estimated or anticipated events or results. These factors include, but are not limited to: the impact or unanticipated impact of general economic, political and market factors in North America and internationally, fluctuations in interest rates, inflation and foreign exchange rates, monetary policies, business investment and the health of local and global equity and capital markets, management of market liquidity and funding risks, risks related to investments in private companies and illiquid securities, risks associated with financial instruments, changes in accounting policies and methods used to report financial condition (including uncertainties associated with significant judgments, estimates and assumptions), the effect of applying future accounting changes, business competition, operational and reputational risks, technological changes, cybersecurity risks, changes in government regulation and legislation, changes in tax laws, unexpected judicial or regulatory proceedings, catastrophic events, man-made disasters, terrorist attacks, wars and other conflicts, or an outbreak of a public health pandemic or other public health crises, the Corporation’s and its subsidiaries’ ability to complete strategic transactions, integrate acquisitions and implement other growth strategies, and the Corporation’s and its subsidiaries’ success in anticipating and managing the foregoing factors.

The reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including, without limitation, management’s perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances, including that the offerings will proceed as currently contemplated and that the list of factors in the previous paragraph, collectively, are not expected to have a material impact on the Corporation and its subsidiaries. While the Corporation considers these assumptions to be reasonable based on information currently available to management, they may prove to be incorrect.

Other than as specifically required by applicable Canadian law, the Corporation undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Additional information about the risks and uncertainties of the Corporation’s business and material factors or assumptions on which information contained in forward-looking statements is based is provided in its disclosure materials, including its most recent Management’s Discussion and Analysis and Annual Information Form, filed with the securities regulatory authorities in Canada and available at www.sedar.com.

SOURCE Power Corporation of Canada